Results 141 to 150 of about 202,439 (195)

Acute COVID-19 is associated with altered CD8 T-cells indicative of impaired ability to control Epstein-Barr virus reactivation. [PDF]

Med Microbiol Immunol
Stervbo U, Anft M, Paniskaki K, Blazquez-Navarro A, Doevelaar A, Skrzypczyk S, Kohut E, Kurek J, Wehler P, Kaliszczyk S, Rosiewicz K, Seibert FS, Hölzer B, Thieme CJ, Roch T, Konik MJ, Berger MM, Brenner T, Kölsch U, Adamzik M, Schmueck-Henneresse M, Scheibenbogen C, Dolff S, Dittmer U, Witzke O, Westhoff TH, Babel N.   +26 more
europepmc   +1 more source

Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future. [PDF]

Neurol Neuroimmunol Neuroinflamm
Wahbeh F, Sabatino JJ.
europepmc   +1 more source

Hemophagocytic syndrome caused by Epstein-Barr virus and cytomegalovirus infection during neoadjuvant chemoradiotherapy for rectal cancer: a case report. [PDF]

Front Med (Lausanne)
Kanesada K, Yoshimatsu K, Yano S, Higashida M, Okada T, Endo S, Fujiwara Y, Ueno T.   +7 more
europepmc   +1 more source

Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis. [PDF]

Neurol Neuroimmunol Neuroinflamm
McCutcheon KM, Bodansky A, Ngo TT, Caspar C, Quintana S, Asaki J, Zhou J, Caillier SJ, Sharathchandra A, Waldrop G, Dandekar R, Zorn K, Tubati A, Gupta S, Sabatino JJ, Cuneo R, Oksenberg J, Wallin MT, Cree BAC, Hauser SL, Pleasure S, Derisi J, Wilson MR, and the UCSF ORIGINS/EPIC team.   +23 more
europepmc   +1 more source

Relevance of Epstein-Barr Virus (EBV) miRNAs in EBV-Infected B Cells and B-Cell Lymphomas. [PDF]

Cancers (Basel)
Rueda-Forero NJ, Kluiver J, Koning M, Berg AVD, Diepstra A.   +4 more
europepmc   +1 more source

Causal association between Epstein-Barr virus infection and malignant gynecologic and breast tumors: a two-sample Mendelian randomization study. [PDF]

Discov Oncol
Zhu J, Lu Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epstein–Barr Virus Infection

New England Journal of Medicine, 2000
The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr.1 Four years later, in 1968, EBV was shown to be the etiologic agent of heterophile-positive infectious mononucleosis.2 EBV DNA was detected in tissues from patients with nasopharyngeal carcinoma ...
Jeffrey I Cohen
openaire   +4 more sources

Epstein Barr Virus hepatitis

European Journal of Internal Medicine, 2011
Epstein-Barr Virus (EBV) infection has the potential to establish life-long, benign infections in their hosts. Although biochemical evidence of hepatocellular damage is common, jaundice is uncommon and complete recovery is the rule. The present study describes clinical characteristics and changes of liver function tests during the course of infectious ...
Diamantis P, Kofteridis, Mairi, Koulentaki, Antonios, Valachis, Maria, Christofaki, Elias, Mazokopakis, George, Papazoglou, George, Samonis   +6 more
openaire   +2 more sources

Epstein-Barr virus dacryoadenitis

American Journal of Ophthalmology, 2000
To describe the clinical features of lacrimal gland inflammation associated with Epstein-Barr virus infection.The clinical records, laboratory data, and radiographs of patients who had inflammation of one or both lacrimal glands that had begun less than 4 weeks previously were reviewed.Sixteen patients with dacryoadenitis were encountered between 1980 ...
M N, Rhem, K R, Wilhelmus, D B, Jones
openaire   +2 more sources